Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD)

ClinicalTrials.gov ID: NCT03260205

Public ClinicalTrials.gov record NCT03260205. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 3:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-blind, Multicenter, Parallel-group, Placebo-controlled, Fixed-Dose Safety and Efficacy Study of SPD489 Compared With Placebo in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine if an investigational treatment is effective in improving the total score on the ADHD-RS-IV Preschool Version in children 4-5 years old diagnosed with ADHD.

Study identification

NCT ID
NCT03260205
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Shire
Industry
Enrollment
199 participants

Conditions and interventions

Eligibility (public fields only)

Age range
4 Years to 5 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 6, 2017 (Actual)
Primary completion
Oct 23, 2018 (Actual)
Completion
Oct 23, 2018 (Actual)
Last update posted
Jun 8, 2021

2017 – 2018

United States locations

U.S. sites
48
U.S. states
21
U.S. cities
42
Facility City State ZIP Site status
Harmonex, Inc Dothan Alabama 36303 —
Preferred Research Partners, Inc Little Rock Arkansas 72211 —
CMB Clinical Trials Colton California 92324 —
Sun Valley Research Center Imperial California 92251 —
Alliance for Wellness d/b/a Alliance for Research Long Beach California 90807 —
Asclepes Research Panorama City California 91402 —
Psychiatric Centers at San Diego San Diego California 92108 —
UCSF Dept of Psychiatry San Francisco California 94143 —
Elite Clinical Trials, Inc Wildomar California 92595 —
Avail Clinical Research, LLC DeLand Florida 32720 —
Sarkis Clinical Trials Gainesville Florida 32607 —
Clinical Neuroscience Solutions, Inc. Jacksonville Florida 32256 —
Medical Research Group of Central Florida Orange City Florida 32763 —
Clinical Neuroscience Solutions Orlando Florida 32801 —
APG Research, LLC Orlando Florida 32803 —
University of South Florida St. Petersburg Florida 33701 —
University of South Florida Department Of Psychiatry Tampa Florida 33613 —
iResearch Atlanta LLC Decatur Georgia 30030 —
Lake Charles Clinical Trials Lake Charles Louisiana 70629 —
Kennedy Krieger Institute Baltimore Maryland 21205 —
Rochester Center for Behavioral Medicine Rochester Hills Michigan 48306 —
Clinical Neurophysiology Services Sterling Heights Michigan 48314 —
Washington University St Louis Missouri 63110 —
Premier Psychiatric Reseach Institute, LLC Lincoln Nebraska 68526 —
Jersey Shore University Medical Center (JSUMC) Neptune City New Jersey 07753 —
Manhattan Behavioral Medicine New York New York 10036 —
University of Rochester Rochester New York 14642 —
University Hospitals Case Medical Center Cleveland Ohio 44106 —
Pediatric Associates of Fairfield, Inc Fairfield Ohio 45014 —
IPS Research Company Oklahoma City Oklahoma 73103 —
Oklahoma Clinical Research Center Oklahoma City Oklahoma 73112 —
Paradigm Research Professionals Oklahoma City Oklahoma 73118 —
Cutting Edge Research Group Oklahoma City Oklahoma 73120 —
Cyn3rgy Research Center Gresham Oregon 97030 —
Rainbow Research Inc Barnwell South Carolina 29812 —
Carolina Clinical Trials, Inc. Charleston South Carolina 29407 —
Coastal Carolina Research Mt. Pleasant South Carolina 29464 —
Clinical Neuroscience Solutions, Inc Memphis Tennessee 38119 —
BioBehavioral Research of Austin Austin Texas 78759 —
Bayou City Research Limited Houston Texas 77007 —
BI Research Center Houston Texas 77084 —
Red Oak Psychiatry Associates Houston Texas 77090 —
Road Runner Research San Antonio Texas 78249 —
Family Psychiatry of the Woodlands The Woodlands Texas 77381 —
Ericksen Research and Development Clinton Utah 84015 —
Clinical Research Partners, LLC Petersburg Virginia 23805 —
Northwest Clinical Research Center Bellevue Washington 98007 —
Seattle Childrens Hospital, Pearl Clinic Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03260205, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 8, 2021 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03260205 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →